Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy

Cancer Biology and Medicine

Volumn 12, Issue 3, 2015, Pages 259-

  Teixidó, Cristina ^a   Karachaliou, Niki ^a   González Cao, Maria ^a   Morales Espinosa, Daniela ^a   Rosell, Rafael ^a,b  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERROR;

EID: 84944314045     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.7497/j.issn.2095-3941.2015.0055     Document Type: Article

References (2)

1. Teixidó C, Karachaliou N, González-Cao M, Morales-Espinosa D, Rosell R. Assays for predicting and monitoring responses to lung cancer immunotherapy. Cancer Biol Med 2015;12:87-95.
2. Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 2015;372:2018-2028.